Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain ketamine, astrocytic inhibitor and pain
- PMID: 20815929
- PMCID: PMC2942826
- DOI: 10.1186/1744-8069-6-50
Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain ketamine, astrocytic inhibitor and pain
Abstract
Background: Neuropathic pain is an intractable clinical problem. Intrathecal ketamine, a noncompetitive N-methyl-D-aspartate receptor (NMDAR) antagonist, is reported to be useful for treating neuropathic pain in clinic by inhibiting the activity of spinal neurons. Nevertheless, emerging studies have disclosed that spinal astrocytes played a critical role in the initiation and maintenance of neuropathic pain. However, the present clinical therapeutics is still just concerning about neuronal participation. Therefore, the present study is to validate the coadministration effects of a neuronal noncompetitive N-methyl-D-aspartate receptor (NMDAR) antagonist ketamine and astrocytic cytotoxin L-α-aminoadipate (LAA) on spinal nerve ligation (SNL)-induced neuropathic pain.
Results: Intrathecal ketamine (10, 100, 1000 μg/kg) or LAA (10, 50, 100 nmol) alleviated SNL-induced mechanical allodynia in a dose-dependent manner respectively. Phosphorylated NR1 (pNR1) or glial fibrillary acidic protein (GFAP) expression was down-regulated by intrathecal ketamine (100, 1000 μg/kg) or LAA (50, 100 nmol) respectively. The combination of ketamine (100 μg/kg) with LAA (50 nmol) showed superadditive effects on neuropathic pain compared with that of intrathecal administration of either ketamine or LAA alone. Combined administration obviously relieved mechanical allodynia in a quick and stable manner. Moreover, down-regulation of pNR1 and GFAP expression were also enhanced by drugs coadministration.
Conclusions: These results suggest that combining NMDAR antagonist ketamine with an astrocytic inhibitor or cytotoxin, which is suitable for clinical use once synthesized, might be a potential strategy for clinical management of neuropathic pain.
Figures





Similar articles
-
Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model.PLoS One. 2013 Apr 9;8(4):e60733. doi: 10.1371/journal.pone.0060733. Print 2013. PLoS One. 2013. PMID: 23585846 Free PMC article.
-
Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain.J Neuroinflammation. 2011 Jan 24;8(1):6. doi: 10.1186/1742-2094-8-6. J Neuroinflammation. 2011. PMID: 21255465 Free PMC article.
-
Inhibiting astrocytic activation: a novel analgesic mechanism of ketamine at the spinal level?J Neurochem. 2009 Jun;109(6):1691-700. doi: 10.1111/j.1471-4159.2009.06087.x. Epub 2009 Apr 4. J Neurochem. 2009. PMID: 19383087
-
Elucidation of pathophysiology and treatment of neuropathic pain.Cent Nerv Syst Agents Med Chem. 2012 Dec;12(4):304-14. doi: 10.2174/187152412803760645. Cent Nerv Syst Agents Med Chem. 2012. PMID: 23033930 Review.
-
Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain.Expert Rev Clin Pharmacol. 2011 May;4(3):379-88. doi: 10.1586/ecp.11.17. Expert Rev Clin Pharmacol. 2011. PMID: 21686074 Free PMC article. Review.
Cited by
-
Ketamine: 50 Years of Modulating the Mind.Front Hum Neurosci. 2016 Nov 29;10:612. doi: 10.3389/fnhum.2016.00612. eCollection 2016. Front Hum Neurosci. 2016. PMID: 27965560 Free PMC article. Review.
-
Contributions of p38 and ERK to the antinociceptive effects of TGF-β1 in chronic constriction injury-induced neuropathic rats.J Headache Pain. 2016 Dec;17(1):72. doi: 10.1186/s10194-016-0665-2. Epub 2016 Aug 19. J Headache Pain. 2016. PMID: 27541934 Free PMC article.
-
Spinal astrocytic activation is involved in a virally-induced rat model of neuropathic pain.PLoS One. 2011;6(9):e23059. doi: 10.1371/journal.pone.0023059. Epub 2011 Sep 28. PLoS One. 2011. PMID: 21969850 Free PMC article.
-
Ketamine Use for Cancer and Chronic Pain Management.Front Pharmacol. 2021 Feb 2;11:599721. doi: 10.3389/fphar.2020.599721. eCollection 2020. Front Pharmacol. 2021. PMID: 33708116 Free PMC article. Review.
-
Spinal astrocytic activation contributes to mechanical allodynia in a rat chemotherapy-induced neuropathic pain model.PLoS One. 2013 Apr 9;8(4):e60733. doi: 10.1371/journal.pone.0060733. Print 2013. PLoS One. 2013. PMID: 23585846 Free PMC article.
References
-
- Xing GG, Liu FY, Qu XX, Han JS, Wan Y. Long-term synaptic plasticity in the spinal dorsal horn and its modulation by electroacupuncture in rats with neuropathic pain. Exp Neurol. 2007;208:323–332. - PubMed
-
- Kiefer RT, Rohr P, Ploppa A, Dieterich HJ, Grothusen J, Koffler S, Altemeyer KH, Unertl K, Schwartzman RJ. Efficacy of Ketamine in Anesthetic Dosage for the Treatment of Refractory Complex Regional Pain Syndrome: An Open-Label Phase II Study. Pain Med. 2008;9:1173–1201. doi: 10.1111/j.1526-4637.2007.00402.x. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous